In patients with T2D and CKD, finerenone lowers the risk for adverse cardiovascular and kidney events compared with placebo, ...
Fecal microbiota transplantation offers no clear benefit in reducing symptoms of irritable bowel syndrome, a meta-analysis finds.
Yet one major bottleneck remains: obtaining timely cardiac imaging information that can help guide management decisions. A ...
The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active ...
From personal experiences to injury to patient success stories, exercise never figured prominently in these doctors’ practice ...
EMA’s positive opinion would lower the approved age for Imvanex from 12 years to 2 years for smallpox, mpox, and vaccinia ...
A novel knee distraction technique is drawing interest for severe osteoarthritis, with studies showing lasting symptom relief ...
The next diagnostic manual is expected to place greater emphasis on evidence-based science, biomarkers, and AI, with the goal ...
A phase 3 trial evaluates the efficacy of mezigdomide plus carfilzomib and dexamethasone vs carfilzomib and dexamethasone in ...
In most patients with mild-to-moderate cholangitis, performing ERCP within 24-48 hours appears to be as effective as ...
With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...
Even with some grants restored, researchers say the deeper damage is harder to undo — and a proposed federal rule could make nonscientific control of science permanent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results